VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 04/30/2023 | 10/31/2022 | 07/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | 4,168.26% | 791.46% | 791.46% | 859.22% |
| Total Depreciation and Amortization | -- | 230.43% | 1,800.00% | 1,800.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -11.48% | -13.64% | -8.53% | 40.40% |
| Change in Net Operating Assets | -- | -435.55% | -3,922.55% | -3,974.31% | -3,040.11% |
| Cash from Operations | -- | -220.72% | -207.59% | -207.59% | -195.66% |
| Capital Expenditure | -- | 100.00% | 53.41% | 53.41% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 53.41% | 53.41% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -45.05% | -45.05% | -45.05% | -45.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -42.86% | -42.86% | -42.86% | -42.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -189.03% | -196.59% | -196.59% | -180.59% |